04:43 PM EST, 03/06/2024 (MT Newswires) -- Regenxbio ( RGNX ) plans to sell $125 million in common stock in an underwritten public offering.

The company said late Wednesday it intends to grant underwriters a 30-day option to purchase up to 15% of the stock sold in the offering as additional shares.

Shares of the company fell 3.1% in after-hours activity.

Price: 23.25, Change: -0.75, Percent Change: -3.13